Endolymphatic Hydrops Grade M2 Correlates Most Strongly With Hearing Loss

THURSDAY, June 1, 2023 (HealthDay News) -- M2 grading of intracochlear endolymphatic hydrops shows the strongest correlation with hearing loss with Meniere disease, according to a study published online May 17 in Acta Oto-Laryngologica.
Zhihao Han, from the Capital Medical University in Beijing, and colleagues compared the grading consistency and correlation between different grade methods of intracochlear endolymphatic hydrops and hearing loss. The analysis included 31 patients diagnosed with Meniere disease who underwent gadolinium-enhanced magnetic resonance imaging.
The researchers found that the weighted kappa coefficients for interobserver and intraobserver agreements for grading cochlea endolymphatic hydrops using M1 were good, while they were excellent for M2, M3, and M4. Based on M2 cochlear endolymphatic hydrops degree, there was correlation with the low-to-mid frequencies, high frequencies, full frequencies, and Meniere disease clinical stage. For degrees based on M1, M3, and M4, correlations were only relevant for some of the four factors.
"In this study, we summarized the four currently prevailing methods to assess cochlear endolymphatic hydrops. Furthermore, we compared the interobserver and intraobserver agreements of the different methods," the authors write. "The results showed that M2 performed better than the other three methods. Therefore, we recommend the use of M2 for evaluating cochlear endolymphatic hydrops."
Related Posts
Prevalence of Metabolic Syndrome 32 Percent in Psoriasis Patients
WEDNESDAY, June 22, 2022 (HealthDay News) -- The global prevalence of metabolic...
COVID-19 Hospitalization Tied to Higher Death Rate Than the Flu
TUESDAY, April 11, 2023 (HealthDay News) -- Being hospitalized for COVID-19 is...
Sackler Family and Purdue Pharma Reach Deal With U.S. States Over Opioid Crisis
THURSDAY, March 3, 2022 (HealthDay News) -- A deal has been reached between...
¿Cuál es la clasificación de su estado en atención de la salud?
JUEVES, 22 de junio de 2023 (HealthDay News) -- Las personas que viven en...